1Y Annualised Return
▼-40.46%
3Y Annualised Return
▼-18.68%
5Y Annualised Return
▼-11.78%
10Y Annualised Return
▼-0.60%
|
|
|
Over the past
Market Cap (in crs)
117.60
Face Value
10
Turnover (in lacs)
32.10
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
57.35 Cr | 73.04 Cr | 88.71 Cr | 79.94 Cr | 76.54 Cr |
Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 |
---|---|---|---|
318.73 Cr | 368.69 Cr | 533.48 Cr | 303.32 Cr |
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
-13.8 Cr | 0.06 Cr | 1.29 Cr | 2.69 Cr | 2.68 Cr |
Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 |
---|---|---|---|
6.72 Cr | -9.07 Cr | 12.31 Cr | 2.65 Cr |
Mangalam Drugs and Organics Ltd reported a 43.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 25.1%.
Its expenses for the quarter were down by 28.5% QoQ and 7.4% YoY.
The net profit decreased 490.9% QoQ and decreased 614.9% YoY.
The earnings per share (EPS) of Mangalam Drugs and Organics Ltd declined at 8.7 during Q1 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 29128 Rs | 46275 Rs |
Week Rs | 28685 Rs | 51112 Rs |
Month Rs | 22966 Rs | 46073 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9.73 | 109.47 | 6.4 | 15.89 | 10.24 | -18.37% | 1.88% | 39.40% | 32.74% | 23.32% | 0.00% | 3.96 | 31.68 | 1.07 | |
92.89 | 128.90 | 87.99 | 193 | 93.63 | -1.96% | -7.48% | -14.43% | -43.15% | 21.50% | 1.61% | 15.20 | 40.09 | 1.51 | |
96.41 | 118.63 | 81.01 | 348.45 | 94.52 | -0.09% | -8.88% | -7.87% | -62.44% | -41.82% | 0.00% | 8.38 | 40.09 | 1.20 | |
5.00 | 117.78 | 2.82 | 6.25 | 5.14 | -3.10% | 13.64% | 45.35% | 40.85% | 481.40% | 0.00% | 250.00 | 40.09 | 3.76 | |
Zenith Drugs Ltd. | - | 68.55 | - | - | - | - | - | - | - | - | - | - | - | - |
55.77 | 111.56 | 55 | 104.9 | 57.50 | -8.42% | -9.02% | -37.62% | 0.00% | 0.00% | 0.00% | 10.40 | 40.09 | 1.61 |
Mangalam Drugs and Organics share price is ₹74.3 in NSE and ₹74.18 in BSE as on 29/8/2025.
Mangalam Drugs and Organics share price in the past 1-year return was -43.12. The Mangalam Drugs and Organics share hit a 1-year low of Rs. 70.1 and a 1-year high of Rs. 140.5.
The market cap of Mangalam Drugs and Organics is Rs. 117.6 Cr. as of 29/8/2025.
The PE ratios of Mangalam Drugs and Organics is 0 as of 29/8/2025.
The PB ratios of Mangalam Drugs and Organics is 0.78 as of 29/8/2025
You can easily buy Mangalam Drugs and Organics shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Mangalam Drugs and Organics share price is ₹140.5 and ₹70.1 as of 29/8/2025.
The earnings per share (EPS) of Mangalam Drugs and Organics declined at 8.7 during Q1 FY 2025-26.
Please be aware that Mangalam Drugs and Organics stock prices are subject to continuous fluctuations due to various factors.